Yori Silvana C, Agrimbau Vázquez Jorge, Berberian Griselda, Curtti Tamara, Urrutia Luis
Fundación Garrahan, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos Aires, Argentina.
Área ambulatoria, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos Aires, Argentina.
Arch Argent Pediatr. 2022 Jun;120(3):e147-e150. doi: 10.5546/aap.2022.e147.
The multisystem inflammatory syndrome in children temporally related to COVID-19 (MIS-C) is a rare disease in pediatrics, which emerges related to the SARS-CoV-2 pandemic and was initially described in May 2020. Given the short time of evolution of this disease, little is known about the pathophysiology, prognosis, and the possibility of recurrence. We present a clinical case of a 12-year-old patient who presented symptoms compatible with MIS-C in January 2021, with good subsequent clinical evolution. He developed reinfection by SARS-CoV-2 at five months later (June 2021), with mild symptoms and without recurrence of MIS-C.
儿童多系统炎症综合征（MIS-C）与2019冠状病毒病（COVID-19）在时间上相关，是儿科的一种罕见疾病，它与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行相关出现，并于2020年5月首次被描述。鉴于这种疾病的病程较短，人们对其病理生理学、预后及复发可能性知之甚少。我们报告一例12岁患者的临床病例，该患者于2021年1月出现与MIS-C相符的症状，随后临床进展良好。五个月后（2021年6月），他再次感染SARS-CoV-2，症状轻微，且未出现MIS-C复发。
